AKT1 and nasopharyngeal carcinoma: miR-335-5p and miR-15b-5p suppress the metastasis of NPC by targeting TRIM29 and inhibit the activity of the PI3K/AKT/mTOR signaling pathway (56); miR-122 inhibits tumor progression by downregulating TRIM29 and repressing the activity of PI3K/AKT signaling (53).